Ignite Creation Date:
2024-05-06 @ 8:53 AM
Last Modification Date:
2024-10-26 @ 12:06 PM
Study NCT ID:
NCT02849977
Status:
COMPLETED
Last Update Posted:
2022-11-15
First Post:
2016-07-26
Brief Title:
Genetic Testing and Phenotypic Characterization of Severely Obese Pediatric and Adult Volunteers
Sponsor:
Rhythm Pharmaceuticals Inc
Organization:
Rhythm Pharmaceuticals Inc
Study Overview
Official Title:
Genetic Testing and Phenotypic Characterization of Severely Obese Pediatric and Adult Volunteers
Status:
COMPLETED
Status Verified Date:
2022-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this screening study is to identify people who have a rare genetic cause of obesity - specifically three genetic variants a change in the DNA structure of the POMC PCSK1 and LepR genes that are currently known to result in obesity
This screening study will not include any investigational drugs You will be asked to provide a DNA sample and answer some questions about your medical history and hunger
This screening study will not include any investigational drugs You will be asked to provide a DNA sample and answer some questions about your medical history and hunger
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None